FR2001036A1 - - Google Patents

Info

Publication number
FR2001036A1
FR2001036A1 FR6901896A FR6901896A FR2001036A1 FR 2001036 A1 FR2001036 A1 FR 2001036A1 FR 6901896 A FR6901896 A FR 6901896A FR 6901896 A FR6901896 A FR 6901896A FR 2001036 A1 FR2001036 A1 FR 2001036A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR6901896A
Other versions
FR2001036B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SERONO IST FARM
Merck Serono SpA
Original Assignee
SERONO IST FARM
Istituto Farmacologico Serono SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SERONO IST FARM, Istituto Farmacologico Serono SpA filed Critical SERONO IST FARM
Publication of FR2001036A1 publication Critical patent/FR2001036A1/fr
Application granted granted Critical
Publication of FR2001036B1 publication Critical patent/FR2001036B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00Chemical modification by after-treatment

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR6901896A 1968-01-31 1969-01-30 Expired FR2001036B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT12243/68A IT1053674B (it) 1968-01-31 1968-01-31 N amidino carbossiamidi ossazoliche ad azione natriuretica

Publications (2)

Publication Number Publication Date
FR2001036A1 true FR2001036A1 (fr) 1969-09-19
FR2001036B1 FR2001036B1 (fr) 1973-12-21

Family

ID=11139626

Family Applications (2)

Application Number Title Priority Date Filing Date
FR6901896A Expired FR2001036B1 (fr) 1968-01-31 1969-01-30
FR707024847A Expired FR2061584B1 (fr) 1968-01-31 1970-07-03

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR707024847A Expired FR2061584B1 (fr) 1968-01-31 1970-07-03

Country Status (7)

Country Link
US (1) US3622595A (fr)
CA (1) CA956963A (fr)
CH (1) CH520701A (fr)
FR (2) FR2001036B1 (fr)
GB (2) GB1263929A (fr)
IT (1) IT1053674B (fr)
SE (1) SE340281B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0676395A2 (fr) * 1994-04-11 1995-10-11 Hoechst Aktiengesellschaft N-heteroaroylguanidines substitués, comme inhibiteurs de l'échange sodium-hydrogène, comme agents antiarrythmiques et comme inhibiteurs de la prolifération des cellules

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1043805B (it) * 1970-03-05 1980-02-29 Serono Ist Farm Ammidi e idrazidi di acidi carbos silici derivanti dal 4,5,difenilossazolo e processo per la loro preparazione
JP2845345B2 (ja) * 1990-11-22 1999-01-13 東亜グラウト工業株式会社 管路の止水方法
US5187188A (en) * 1992-04-03 1993-02-16 Bristol-Myers Squibb Company Oxazole carboxylic acid derivatives
ES2157711B1 (es) * 1998-02-27 2002-03-01 Vilarasau Alegre M Teresa Dispositivo para limpiar conductos de aire.
FR2866340B1 (fr) * 2004-02-13 2006-11-24 Sanofi Synthelabo Derives d'oxazole, leur preparation et leur utilisation en therapeutique.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0676395A2 (fr) * 1994-04-11 1995-10-11 Hoechst Aktiengesellschaft N-heteroaroylguanidines substitués, comme inhibiteurs de l'échange sodium-hydrogène, comme agents antiarrythmiques et comme inhibiteurs de la prolifération des cellules
EP0676395A3 (fr) * 1994-04-11 1996-03-06 Hoechst Ag N-heteroaroylguanidines substitués, comme inhibiteurs de l'échange sodium-hydrogène, comme agents antiarrythmiques et comme inhibiteurs de la prolifération des cellules.

Also Published As

Publication number Publication date
FR2001036B1 (fr) 1973-12-21
CA956963A (en) 1974-10-29
SE340281B (fr) 1971-11-15
GB1263929A (en) 1972-02-16
GB1263930A (en) 1972-02-16
US3622595A (en) 1971-11-23
FR2061584A1 (fr) 1971-06-25
CH520701A (it) 1972-03-31
IT1053674B (it) 1981-10-10
FR2061584B1 (fr) 1973-01-12

Similar Documents

Publication Publication Date Title
AU5506869A (fr)
AU5184069A (fr)
AU6168869A (fr)
FR2001036B1 (fr)
AU6171569A (fr)
AU2581067A (fr)
AU4811568A (fr)
BE709479A (fr)
BE709320A (fr)
BE726969A (fr)
BE726918A (fr)
BE726479A (fr)
BE723541A (fr)
BE719887A (fr)
BE719631A (fr)
BE719520A (fr)
BE718159A (fr)
BE716071A (fr)
BE709496A (fr)
BE709484A (fr)
BE642636A (fr)
AU4558658A (fr)
AU4464266A (fr)
BE709446A (fr)
BE709435A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse